Nucleai and Sirona Dx to provide new proteomics solution for pharma companies
Nucleai has partnered with Sirona Dx to provide an integrated spatial proteomics solution for pharmaceutical and biotechnology firms for drug development.
By Pharmaceutical Technology
· Apr 16, 2026
· via Pharmaceutical Technology
Image: Pharmaceutical Technology
Tags
theweekformat:headlineheadlinePharmaceutical Technology
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekSTAT News ↗
“These sides aren't talking to each other. And there's a lot riding on it”: The hosts of “Why Should I Trust Y…
The WeekBriefing
KFF’s new weekly podcast debuts April 2026, diving into healthcare’s financial and policy mechanics, starting …
The WeekBriefing
Drug Channels’ April roundup highlights how vertical integration and copay maximizers are changing the economi…